Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Radiation Oncology Market Growth Performance Trended Historically, And What Lies Ahead?

The market size for radiation oncology has seen considerable growth in the past few years. The projected growth from $7.99 billion in 2024 to $8.73 billion in 2025, with a compound annual growth rate (CAGR) of 9.2%, underscores this trend. Reasons for this growth during the historical period include a surge in cancer cases, higher expenditure on healthcare, increased investment in healthcare infrastructure, a growing elderly population, and an increased occurrence of complex cancer cases.

The market size of radiation oncology is projected to experience notable expansion in the coming years. It is anticipated to reach a value of$12.41 billion by 2029, increasing at a compound annual growth rate (CAGR) of 9.2%. Various factors are likely to drive this growth during the forecast period, including enhanced demand for precision treatments, the enlargement of outpatient cancer facilities, the growing utilization of treatment planning software, escalating government initiatives toward cancer care, and the expansion of healthcare infrastructure. The aforementioned period is expected to witness significant trends such as customized treatment plans, high-resolution imaging, AI-assisted imaging, stereotactic body radiation therapy (SBRT), and progress in brachytherapy.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23494&type=smp

What Are the Core Market Drivers Propelling Growth in the Radiation Oncology Industry?

The radiation oncology market is set to expand, driven largely by the rising number of cancer patients. Cancer, a disease caused by the uncontrolled proliferation and dissemination of abnormal cells within the body, is diagnosed in these individuals. The surge in the number of cancer patients can largely be attributed to the prevalent adoption of unhealthy lifestyles that significantly amplifies the risk of cancer. Radiation oncology uses high-energy radiation to kill cancer cells, reduce tumor size, alleviate symptoms, and enhance the efficiency of surgery and chemotherapy – with newer methods enhancing accuracy and results. For example, the UK’s National Health Service reported in October 2024 that there were 346,217 new cancer diagnoses in 2022, averaging 948 daily. This number is an increase from 329,664 in 2021, reflecting a 5% growth. Consequently, the escalating number of cancer patients is fuelling the expansion of the radiation oncology market.

How Is the Radiation Oncology Market Segmented?

The radiation oncologymarket covered in this report is segmented –

1) By Type: External Beam Radiation Therapy; Internal Beam Radiation Therapy

2) By Application: Prostate Cancer; Breast Cancer; Lung Cancer; Head And Neck Cancer; Colorectal Cancer; Cervical Cancer; Gynecological Cancer; Other Applications

3) By End-User: Hospitals; Cancer Research Institutes; Other End-Users

Subsegments:

1) By Internal Beam Radiation Therapy; Brachytherapy; Endocavitary Brachytherapy; Interstitial Brachytherapy; Intraluminal Brachytherapy

2) By External Beam Radiation Therapy; 3D Conformal Radiation Therapy (3DCRT); Intensity-Modulated Radiation Therapy (IMRT); Stereotactic Radiosurgery (SRS); Stereotactic Body Radiation Therapy (SBRT); Image-Guided Radiation Therapy (IGRT)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=23494&type=smp

Which Regions Are Driving the Next Phase of the Radiation Oncology Market Growth?

North America was the largest region in the radiation oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radiation oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Radiation Oncology Industry?

Leading firms in the radiation oncology sector are concentrating on the development of state-of-the-art radiation therapy systems that incorporate AI-enabled imaging and adaptive technology. This is with the view to boost accuracy in treatment, minimize side effects, and enhance patient results across different cancer care applications. AI-based radiotherapy signifies the application of artificial intelligence technologies to improve diverse features of radiation therapy, including treatment design, imaging, delivery, and tracking. As an example, in May 2024, Elekta, a prestigious medical tech company from Sweden, introduced their latest CT-Linac, Evo. This system includes a high-definition AI-backed imaging designed to ameliorate radiation therapy methods. This versatile system is designed to support both offline and online adaptive radiation therapy, supplementing enhanced standard image-guided radiation therapy. This gives healthcare providers greater precision and adaptability for customizing treatments for each patient. The main goal of this innovation is to improve patient results by optimising treatment accuracy and adaptability.

View the full report here:

https://www.thebusinessresearchcompany.com/report/radiation-oncology-global-market-report

How Is the Radiation Oncology Market Defined and What Are Its Core Parameters?

Radiation oncology refers to a specialized area of medicine where high-energy radiation is used to treat cancer by damaging the deoxyribonucleic acid (DNA) of malignant cells, thereby preventing their growth and spread. This approach utilizes advanced methods to provide precise treatment, focusing on targeting the affected area while minimizing harm to surrounding healthy tissues.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23494

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model